Article
Recombinant human soluble thrombomodulin is associated with attenuation of sepsis-induced…
medRxiv · 2019 · Akatsuka, M.; Masuda, Y.; Tatsumi, H.; Yamakage, M.
Key facts
| Title | Recombinant human soluble thrombomodulin is associated with attenuation of sepsis-induced renal impairment by inhibition of extracellular histone release |
|---|---|
| First author | Akatsuka, M.; Masuda, Y.; Tatsumi, H.; Yamakage, M. |
| Journal | medRxiv |
| Published | Dec 9, 2019 |
| DOI | 10.1101/780403 |
| Product codes mentioned | NJT |
At a glance
- None FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1